Annotation Detail for CACNA2D3

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04010 | MAPK signaling pathway |
hsa05410 | Hypertrophic cardiomyopathy (HCM) |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
hsa05414 | Dilated cardiomyopathy |
hsa04260 | Cardiac muscle contraction |
Pathway ID | Pathway Name |
---|
| Synaptic Transmission |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CACNA2D3 mRNA | affects expression | 16483693
|
D007052 |
Ibuprofen |
Ibuprofen affects the expression of CACNA2D3 mRNA | affects expression | 17070997
|
D037742 |
Nanotubes, Carbon |
Nanotubes, Carbon results in decreased expression of CACNA2D3 mRNA | decreases expression | 15585362
|
C116926 |
rofecoxib |
rofecoxib results in decreased expression of CACNA2D3 mRNA | decreases expression | 17070997
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of CACNA2D3 mRNA | increases expression | 18175754
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CACNA2D3 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Ibuprofen |
4.77 | 6375363 |
MESH:D000230 |
Adenocarcinoma |
|
Ibuprofen |
3.31 | 10697514 |
MESH:D000544 |
Alzheimer Disease |
|
Ibuprofen |
3.22 | 18351690 |
MESH:D000707 |
Anaphylaxis |
|
Ibuprofen |
5.66 | 9532969 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.89 | 19015723 |
MESH:D001169 |
Arthritis, Experimental |
|
rofecoxib |
4.52 | 16690336 |
MESH:D002545 |
Brain Ischemia |
|
Ibuprofen |
5.34 | 15837124 |
MESH:D002100 |
Cachexia |
|
Ibuprofen |
5.93 | 15141370 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D003110 |
Colonic Neoplasms |
|
rofecoxib |
3.34 | 12902858 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.72 | 14966744 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.35 | 15131321 |
MESH:D004374 |
Ductus Arteriosus, Patent |
|
Ibuprofen |
6.08 | 18450898 18446180 16133044 |
MESH:D004715 |
Endometriosis |
|
Ibuprofen |
10.95 | 15652904 |
MESH:D004715 |
Endometriosis |
|
rofecoxib |
10.95 | 15652904 |
MESH:D019446 |
Endotoxemia |
|
Ibuprofen |
5.43 | 11545620 |
MESH:D005334 |
Fever |
|
Ibuprofen |
4.89 | 16997862 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.40 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.82 | 16417039 |
MESH:D006984 |
Hypertrophy |
|
Ibuprofen |
5.30 | 16672835 |
MESH:D007235 |
Infant, Premature, Diseases |
|
Ibuprofen |
6.36 | 16133044 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.24 | 16467254 |
MESH:D007249 |
Inflammation |
|
Ibuprofen |
3.58 | 3291741 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
rofecoxib |
5.45 | 15831440 |
MESH:D007417 |
Intestinal Polyps |
|
rofecoxib |
5.72 | 11245490 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.19 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rofecoxib |
3.08 | 17565644 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ibuprofen |
3.89 | 10697514 |
MESH:D009395 |
Nephritis, Interstitial |
|
Ibuprofen |
5.50 | 6375363 |
MESH:D009410 |
Nerve Degeneration |
|
Ibuprofen |
4.63 | 10961664 |
MESH:D010003 |
Osteoarthritis |
|
Ibuprofen |
8.88 | 7009135 |
MESH:D010003 |
Osteoarthritis |
|
rofecoxib |
8.88 | 16690336 |
MESH:D010146 |
Pain |
|
Ibuprofen |
4.19 | 3291741 |
MESH:D010149 |
Pain, Postoperative |
|
Ibuprofen |
13.54 | 16678543 |
MESH:D010149 |
Pain, Postoperative |
|
rofecoxib |
13.54 | 18165598 16678543 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ibuprofen |
3.57 | 12384795 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.36 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.40 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ibuprofen |
3.62 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.62 | 18760546 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.40 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Ibuprofen |
4.98 | 6375363 |
MESH:D020301 |
Vasospasm, Intracranial |
|
Ibuprofen |
5.65 | 19057314 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00381 |
antagonist |
Lotrel |
Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers;Antianginals |
DB06712 |
antagonist |
Nilvadipine |
Antihypertensive Agents;Calcium Channel Blockers |